Martina Pennisi

2.3k total citations
29 papers, 612 citations indexed

About

Martina Pennisi is a scholar working on Oncology, Immunology and Electrical and Electronic Engineering. According to data from OpenAlex, Martina Pennisi has authored 29 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 8 papers in Immunology and 8 papers in Electrical and Electronic Engineering. Recurrent topics in Martina Pennisi's work include CAR-T cell therapy research (20 papers), Integrated Circuits and Semiconductor Failure Analysis (7 papers) and Advancements in Semiconductor Devices and Circuit Design (7 papers). Martina Pennisi is often cited by papers focused on CAR-T cell therapy research (20 papers), Integrated Circuits and Semiconductor Failure Analysis (7 papers) and Advancements in Semiconductor Devices and Circuit Design (7 papers). Martina Pennisi collaborates with scholars based in Italy, United States and Thailand. Martina Pennisi's co-authors include Miguel‐Angel Perales, Molly Maloy, Gunjan L. Shah, Aishat Olaide Afuye, Connie Lee Batlevi, Michael Scordo, Parastoo B. Dahi, Jessica Flynn, Bianca Santomasso and Marta García‐Recio and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer.

In The Last Decade

Martina Pennisi

27 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martina Pennisi Italy 12 520 153 134 103 92 29 612
Gloria Iacoboni Spain 16 588 1.1× 120 0.8× 103 0.8× 102 1.0× 111 1.2× 65 730
Xia Mao China 16 512 1.0× 79 0.5× 123 0.9× 235 2.3× 180 2.0× 66 741
Evandro D. Bezerra United States 9 393 0.8× 89 0.6× 95 0.7× 80 0.8× 56 0.6× 31 523
Hien Liu United States 11 449 0.9× 118 0.8× 91 0.7× 156 1.5× 67 0.7× 62 594
Quanshun Wang China 10 755 1.5× 83 0.5× 241 1.8× 285 2.8× 245 2.7× 63 1.0k
Ana Cordeiro Brazil 5 332 0.6× 80 0.5× 89 0.7× 56 0.5× 47 0.5× 21 400
Shalev Fried Israel 7 313 0.6× 64 0.4× 134 1.0× 87 0.8× 52 0.6× 25 390
Haneen Shalabi United States 15 777 1.5× 167 1.1× 222 1.7× 172 1.7× 124 1.3× 47 866
Chunrong Tong China 11 337 0.6× 61 0.4× 86 0.6× 108 1.0× 113 1.2× 50 450
Sarah Nagle United States 10 296 0.6× 60 0.4× 48 0.4× 75 0.7× 93 1.0× 29 503

Countries citing papers authored by Martina Pennisi

Since Specialization
Citations

This map shows the geographic impact of Martina Pennisi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martina Pennisi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martina Pennisi more than expected).

Fields of papers citing papers by Martina Pennisi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martina Pennisi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martina Pennisi. The network helps show where Martina Pennisi may publish in the future.

Co-authorship network of co-authors of Martina Pennisi

This figure shows the co-authorship network connecting the top 25 collaborators of Martina Pennisi. A scholar is included among the top collaborators of Martina Pennisi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martina Pennisi. Martina Pennisi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shahid, Zainab, Tania Jain, M. Veronica Dioverti, et al.. (2024). Best Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management After Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies. Transplantation and Cellular Therapy. 30(10). 955–969. 32 indexed citations
2.
Deschênes‐Simard, Xavier, Martina Pennisi, Miguel‐Angel Perales, et al.. (2024). Severe toxicity, but long-term persistence of CAR T cells after immune checkpoint inhibitors in large B-cell lymphoma. Leukemia & lymphoma. 66(3). 535–540.
3.
Reiner, Anne S., Jae H. Park, Martina Pennisi, et al.. (2024). EEG features and synek scale indicate severity of neurotoxicity in adult patients treated with CD19 CAR T-cell therapy. Scientific Reports. 14(1). 29090–29090. 1 indexed citations
4.
Guidetti, Anna, Annamaria De Filippo, Martina Pennisi, et al.. (2023). Nonrestrictive diet does not increase infections during post-HSCT neutropenia: data from a multicenter randomized trial. Blood Advances. 7(19). 5996–6004. 6 indexed citations
5.
Dodero, Anna, Stéfania Bramanti, Martina Di Trani, et al.. (2023). Outcome after chimeric antigen receptor (CAR) T‐cell therapy failure in large B‐cell lymphomas. British Journal of Haematology. 204(1). 151–159. 12 indexed citations
6.
Magni, Martina, Silva Ljevar, Annalisa Chiappella, et al.. (2022). Phenotypic Composition of Commercial Anti-CD19 CAR T Cells Affects In Vivo Expansion and Disease Response in Patients with Large B-cell Lymphoma. Clinical Cancer Research. 28(15). 3378–3386. 35 indexed citations
7.
Riedell, Peter A., Wei‐Ting Hwang, Loretta J. Nastoupil, et al.. (2022). Patterns of Use, Outcomes, and Resource Utilization among Recipients of Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B Cell Lymphomas. Transplantation and Cellular Therapy. 28(10). 669–676. 49 indexed citations
8.
Gutgarts, Victoria, Tania Jain, Junting Zheng, et al.. (2020). Acute Kidney Injury after CAR-T Cell Therapy: Low Incidence and Rapid Recovery. Biology of Blood and Marrow Transplantation. 26(6). 1071–1076. 66 indexed citations
9.
Wudhikarn, Kitsada, Martina Pennisi, Marta García‐Recio, et al.. (2020). DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality. Blood Advances. 4(13). 3024–3033. 85 indexed citations
10.
Riedell, Peter A., Loretta J. Nastoupil, Martina Pennisi, et al.. (2020). A Multicenter Retrospective Analysis of Outcomes and Toxicities with Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B-Cell Lymphomas. Biology of Blood and Marrow Transplantation. 26(3). S41–S42. 27 indexed citations
11.
Jain, Tania, Andrea Knežević, Martina Pennisi, et al.. (2020). Hematopoietic Recovery Following Chimeric Antigen Receptor T Cell (CAR T) Therapy in Hematological Malignancies. Biology of Blood and Marrow Transplantation. 26(3). S63–S64. 1 indexed citations
12.
Wudhikarn, Kitsada, M. Lia Palomba, Martina Pennisi, et al.. (2020). Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma. Blood Cancer Journal. 10(8). 79–79. 161 indexed citations
14.
Mussetti, Alberto, Chiara De Philippis, Cristiana Carniti, et al.. (2018). CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide. Bone Marrow Transplantation. 53(12). 1522–1531. 18 indexed citations
15.
Mussetti, Alberto, et al.. (2018). Real-life feasibility of salvage allogeneic transplantation in peripheral T-cell lymphomas. Bone Marrow Transplantation. 54(8). 1237–1244. 4 indexed citations
16.
Reda, Gianluigi, Marta Riva, Bruno Fattizzo, et al.. (2018). Bone Marrow Fibrosis and Early Hematological Response as Predictors of Poor Outcome in Azacitidine Treated High Risk-Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia. Seminars in Hematology. 55(4). 202–208. 5 indexed citations
17.
Montefusco, Vittorio, Alberto Mussetti, Francesco Maura, et al.. (2017). Allogeneic stem cell transplantation and subsequent treatments as a comprehensive strategy for long-term survival of multiple myeloma patients. Bone Marrow Transplantation. 52(12). 1602–1608. 14 indexed citations
18.
Pennisi, Martina, Clara Cesana, Micol Giulia Cittone, et al.. (2017). A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm Extensively Studied by Flow Cytometry and Immunohistochemistry. SHILAP Revista de lepidopterología. 2017. 1–6. 5 indexed citations
19.
Dodero, Anna, Francesco Maura, Alessio Pellegrinelli, et al.. (2015). GATA-3 Expression in Peripheral T-Cell Lymphomas (PTCL): Identification of a Cut-Off and Prognostic Value in PTCL-NOS Versus Others Hystotypes. Blood. 126(23). 3889–3889. 1 indexed citations
20.
Montefusco, Vittorio, Mónica Galli, Francesco Spina, et al.. (2014). Autoimmune diseases during treatment with immunomodulatory drugs in multiple myeloma: selective occurrence after lenalidomide. Leukemia & lymphoma. 55(9). 2032–2037. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026